Making sense of the food and drug administration - PubMed

Review

Making sense of the food and drug administration

Jessica Anne Connor. Semin Pediatr Surg. 2006 Nov.

Abstract

An examination of and recommendations regarding the approval process for medical devices are presented. The typical pathways and hurdles laid out by the Federal Food and Drug Administration (FDA) are discussed, and options for marketing and use of medical devices are addressed. The first step in the regulatory process is to establish that the new product is, in fact, a medical device. From there, the appropriate classification and the corresponding level of regulatory control that will be required can be identified. The appropriate marketing application will be submitted and is supported by the data necessary to reasonably assure safety and effectiveness. Once the application is submitted, reviewed, and eventually approved, the manufacturer may legally market and sell the medical device. The active involvement of physicians as advisors and innovators in medical device development is imperative to the successful development of safe and effective medical devices. Physicians also fulfill the important obligation of adverse event reporting with all medical devices that they use. The pediatric physician should additionally be aware of the FDA regulations and expectations with respect to devices that will serve pediatric patient populations, of the regulatory options for approval and unapproved use for some devices, and of the special measures taken to protect the rights, safety, and welfare of pediatric patients participating in investigational studies.

Similar articles

• Medical devices; designation of special control for eight surgical suture devices. Final rule.

  Food and Drug Administration, HHS. Food and Drug Administration, HHS. Fed Regist. 2003 Jun 3;68(106):32983-5. Fed Regist. 2003. PMID: 12784826

• Medical devices; classification for medical washer and medical washer-disinfector. Final rule.

  Food and Drug Administration, HHS. Food and Drug Administration, HHS. Fed Regist. 2002 Nov 15;67(221):69119-21. Fed Regist. 2002. PMID: 12437015

• FDA marketing claims, and the practitioner.

  Runner S. Runner S. J Evid Based Dent Pract. 2006 Mar;6(1):19-23. doi: 10.1016/j.jebdp.2005.12.017. J Evid Based Dent Pract. 2006. PMID: 17138391

• Mechanical devices and US Food and Drug Administration (FDA) approval.

  Reitz BA. Reitz BA. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu. 2006:123-7. doi: 10.1053/j.pcsu.2006.02.018. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu. 2006. PMID: 16638557 Review.

• An overview of FDA medical device regulation as it relates to deep brain stimulation devices.

  Peña C, Bowsher K, Costello A, De Luca R, Doll S, Li K, Schroeder M, Stevens T. Peña C, et al. IEEE Trans Neural Syst Rehabil Eng. 2007 Sep;15(3):421-4. doi: 10.1109/TNSRE.2007.903973. IEEE Trans Neural Syst Rehabil Eng. 2007. PMID: 17894274 Review.

Cited by

• Fucosylation in Urological Cancers.

  Fujita K, Hatano K, Hashimoto M, Tomiyama E, Miyoshi E, Nonomura N, Uemura H. Fujita K, et al. Int J Mol Sci. 2021 Dec 11;22(24):13333. doi: 10.3390/ijms222413333. Int J Mol Sci. 2021. PMID: 34948129 Free PMC article. Review.

Publication types

MeSH terms

LinkOut - more resources

• Full Text Sources

  • Elsevier Science

• Miscellaneous

  • NCI CPTAC Assay Portal